Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Schulman

Showing results (221-230 of 240) with videos related to

Pageof 24
Sort By:
Blood|August 26, 1998
A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111R A Larson, R K Dodge, C A Linker, et al.
Blood|July 27, 2001
Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabineR M Stone, D T Berg, S L George, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|August 13, 2014
Troponin elevations only detected with a high-sensitivity assay: clinical correlations and prognostic significanceFrederick K Korley, Steven P Schulman, Lori J Sokoll, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|August 30, 2013
Thromboxane A(2) generation, in the absence of platelet COX-1 activity, in patients with and without atherothrombotic myocardial infarctionAndrew P DeFilippis, Oluwasegun S Oloyede, Efstathia Andrikopoulou, et al.
Blood|September 9, 1999
Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemiaR N Damle, T Wasil, F Fais, et al.
The Journal of Cardiovascular Surgery|November 5, 2011
Relative importance of patient, procedural and anatomic risk factors for early vein graft thrombosis after coronary artery bypass graft surgeryR C McLean, S M Nazarian, T J Gluckman, et al.
The American Journal of Cardiology|March 11, 2005
Incidence of antiplatelet factor 4/heparin antibody induction in patients undergoing percutaneous coronary revascularizationTyler J Gluckman, Jodi B Segal, Natalie L Fredde, et al.
Journal of the American College of Cardiology|December 5, 2009
A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarctionJoshua M Hare, Jay H Traverse, Timothy D Henry, et al.
The Journal of Clinical Investigation|October 1, 1996
Examples of in vivo isotype class switching in IgM+ chronic lymphocytic leukemia B cellsF Fais, B Sellars, F Ghiotto, et al.
Clinical Cardiology|November 1, 1996
Refining the treatment of women with unstable angina--a randomized, double-blind, comparative safety and efficacy evaluation of Integrelin versus aspirin in the management of unstable anginaP J Goldschmidt-Clermont, S P Schulman, P F Bray, et al.
Pageof 24

Showing results (221-230 of 240) with videos related to

Sort By:
Pageof 24
Blood|August 26, 1998
A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111R A Larson, R K Dodge, C A Linker, et al.
Blood|July 27, 2001
Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabineR M Stone, D T Berg, S L George, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|August 13, 2014
Troponin elevations only detected with a high-sensitivity assay: clinical correlations and prognostic significanceFrederick K Korley, Steven P Schulman, Lori J Sokoll, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|August 30, 2013
Thromboxane A(2) generation, in the absence of platelet COX-1 activity, in patients with and without atherothrombotic myocardial infarctionAndrew P DeFilippis, Oluwasegun S Oloyede, Efstathia Andrikopoulou, et al.
Blood|September 9, 1999
Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemiaR N Damle, T Wasil, F Fais, et al.
The Journal of Cardiovascular Surgery|November 5, 2011
Relative importance of patient, procedural and anatomic risk factors for early vein graft thrombosis after coronary artery bypass graft surgeryR C McLean, S M Nazarian, T J Gluckman, et al.
The American Journal of Cardiology|March 11, 2005
Incidence of antiplatelet factor 4/heparin antibody induction in patients undergoing percutaneous coronary revascularizationTyler J Gluckman, Jodi B Segal, Natalie L Fredde, et al.
Journal of the American College of Cardiology|December 5, 2009
A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarctionJoshua M Hare, Jay H Traverse, Timothy D Henry, et al.
The Journal of Clinical Investigation|October 1, 1996
Examples of in vivo isotype class switching in IgM+ chronic lymphocytic leukemia B cellsF Fais, B Sellars, F Ghiotto, et al.
Clinical Cardiology|November 1, 1996
Refining the treatment of women with unstable angina--a randomized, double-blind, comparative safety and efficacy evaluation of Integrelin versus aspirin in the management of unstable anginaP J Goldschmidt-Clermont, S P Schulman, P F Bray, et al.
Pageof 24